Drug candidates in clinical trials for Alzheimer's disease.
about
Modifications and Trafficking of APP in the Pathogenesis of Alzheimer's Disease.Translational Research in Alzheimer's and Prion Diseases.Review: Neuropathology and behavioural features of transgenic murine models of Alzheimer's disease.Beta testing the potential link between the alpha antagonist tamsulosin and dementia.AAVrh.10-mediated APOE2 CNS Gene Therapy for APOE4-associated Alzheimer's Disease.Application of Metabolomics in Alzheimer's Disease.Drug discovery, development and delivery in Alzheimer's disease.The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?Synaptic dysfunction in Alzheimer's disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention.Aptamers Selected for Recognizing Amyloid β-Protein-A Case for Cautious Optimism.A Novel Association of Polymorphism in the ITGA4 Gene Encoding the VLA-4 α4 Subunit with Increased Risk of Alzheimer's Disease.Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer's disease and frontotemporal dementia.Computer-Aided Multi-Target Management of Emergent Alzheimer's Disease.Importance of GPCR-Mediated Microglial Activation in Alzheimer's DiseaseNeuroprotective Effects of the Multitarget Agent AVCRI104P3 in Brain of Middle-Aged Mice
P2860
Q41665323-5C4549D3-6892-40E6-A87A-1EF4AD630B2BQ47368173-473C17A3-3447-4FF1-8307-44FA85B90B49Q48113034-46D87F37-D23C-449D-AD2E-C58C7E34DDFEQ48228477-BA4EDB4C-C036-45E5-BF3F-19532CC4ADB8Q48510056-5376A081-094C-400A-AD6E-9DBA58F049F3Q49464422-C4FE27C2-DCB4-4C9D-8528-495AC9D491A2Q49484168-1793E648-E9A5-4858-9089-97E99F495AB9Q52347539-80305ABA-7ACF-441A-BBE5-B3D2EF8DCD17Q53513746-2DA5B3F2-8840-4D7F-A891-437AB0EF98E3Q55007427-5203C006-D68F-4874-AE62-993B8095AC68Q55259831-76DB0C12-6D19-4F87-B1B5-1FD8B4B735FBQ55345450-74C6C6AA-DB2B-4CF5-8A7F-0E64B249ADFCQ55456183-DEF94B83-6662-415F-9E7B-8AB6970AFA1CQ58729326-B4A03EF1-7AF9-44D2-A000-04A91956CC49Q58764136-C4E02B10-91A7-4378-A459-612FC05B1BF1
P2860
Drug candidates in clinical trials for Alzheimer's disease.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
name
Drug candidates in clinical trials for Alzheimer's disease.
@ast
Drug candidates in clinical trials for Alzheimer's disease.
@en
type
label
Drug candidates in clinical trials for Alzheimer's disease.
@ast
Drug candidates in clinical trials for Alzheimer's disease.
@en
prefLabel
Drug candidates in clinical trials for Alzheimer's disease.
@ast
Drug candidates in clinical trials for Alzheimer's disease.
@en
P2860
P921
P1476
Drug candidates in clinical trials for Alzheimer's disease.
@en
P2093
Shih-Ya Hung
Wen-Mei Fu
P2860
P2888
P356
10.1186/S12929-017-0355-7
P5008
P577
2017-07-19T00:00:00Z
P6179
1090774919